Telemedicine Enhanced Asthma Management - Uniting Providers
TEAM-UP
1 other identifier
interventional
326
1 country
1
Brief Summary
This research study is an innovative school-based program for urban children with moderate to severe persistent or difficult-to-control asthma. The Telemedicine Enhanced Asthma Management-Uniting Providers (TEAM-UP) program enhances a school-based, primary care directed asthma program with specialist-supported care to ensure optimal guideline based treatment. This study is a full-scale randomized trial of TEAM-UP versus an enhanced care comparison group. Primary care physicians (PCP) of all enrolled children (n=360, 4-12 yrs.) will be prompted to initiate directly observed therapy (DOT) of preventive asthma medication through school and to make a specialist referral. For children in the TEAM-UP group, the specialist visits will be facilitated via telemedicine at school. The telemedicine specialist visit will be scheduled after approximately 4 weeks of initiating DOT, in order to allow for accurate guideline-based assessments of medication and care needs once adherence with a daily controller medication is established. There will also be up to 2 telemedicine follow-up specialist visits to assess the child's response to treatment and make needed adjustments. The study will use the existing community infrastructure by implementing both telemedicine and DOT in school, and maintaining collaboration with PCPs. Blinded follow-ups will occur at 3-, 5-, 7- and 12-months after baseline, and the primary outcome is the comparison of symptom-free days (SFD) at each follow-up time point.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2018
CompletedFirst Posted
Study publicly available on registry
June 4, 2018
CompletedStudy Start
First participant enrolled
November 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2025
CompletedResults Posted
Study results publicly available
September 8, 2025
CompletedSeptember 17, 2025
September 1, 2025
5.5 years
May 17, 2018
July 28, 2025
September 5, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Mean Symptom-Free Days in Prior 14 Days
Mean number of symptom-free days in the prior 14 days (range 0-14)
3 months after baseline
Mean Symptom-Free Days in Prior 14 Days
Mean number of symptom-free days in the prior 14 days (range 0-14)
5 months after baseline
Mean Symptom-Free Days in Prior 14 Days
Mean number of symptom-free days in the prior 14 days (range 0-14)
7 months after baseline
Mean Symptom-Free Days in Prior 14 Days
Mean number of symptom-free days in the prior 14 days (range 0-14)
12 months after baseline
Study Arms (2)
TEAM-UP Intervention Group
EXPERIMENTALEnhanced Care Comparison Group
ACTIVE COMPARATORInterventions
Children randomly assigned to TEAM-UP will have a telemedicine assisted specialist visit scheduled after 4 weeks of initiating DOT at school, as well as 2 subsequent follow-up visits. The visits will be performed by a specialist in pediatric asthma, to implement guideline-based care. Prescriptions for asthma medications will be prescribed to be delivered as directly observed therapy in school.
Similar to the TEAM-UP group, children in the Enhanced Care group will receive a symptom assessment and asthma education materials at baseline, and we will contact the PCP by facsimile or email and will recommend DOT of preventive asthma medication through school as well as a referral to specialist. However specialist visits will not be facilitated via telemedicine.
Eligibility Criteria
You may qualify if:
- Physician-diagnosed asthma (based on parent report with validation from the child's physician).
- Age \>=4 and =\<12 years.
- Residence in the City of Rochester and surrounding suburbs, with a. primary residence within the following zip codes: 14445, 14604, 14605, 14606, 14607, 14608, 14609, 14610, 14611, 14612, 14613, 14614, 14615, 14616, 14617, 14618, 14619, 14620, 14621, 14622, 14623, 14624, 14625, 14626.
- Moderate-severe persistent severity (requiring Step 3 or higher care) or difficult to control asthma despite therapy (based on age-specific NHLBI guidelines).
You may not qualify if:
- Inability to speak and understand English or Spanish. (\*Parents unable to read will be eligible, and all instruments will be given verbally.)
- Current participation in an asthma study.
- Planning to leave the Rochester city school district area in fewer than 6 months.
- Having received asthma specialist care in the prior 3 months.
- Having other significant medical conditions, including congenital heart disease, cystic fibrosis, or other chronic lung disease, that could interfere with the assessment of asthma-related measures.
- In foster care or other situations in which consent cannot be obtained from a guardian.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Rochesterlead
- University of Arkansascollaborator
- University at Buffalocollaborator
Study Sites (1)
University of Rochester
Rochester, New York, 14642, United States
Related Publications (1)
Halterman JS, Fagnano M, Tremblay PJ, Perry TT, Wang H, Mustafa SS, Ramsey A, Stern J. Effect of the Telemedicine Enhanced Asthma Management-Uniting Providers (TEAM-UP) Program on Asthma Outcomes: A Randomized Clinical Trial. J Pediatr. 2025 Oct 23;289:114872. doi: 10.1016/j.jpeds.2025.114872. Online ahead of print.
PMID: 41139012DERIVED
Results Point of Contact
- Title
- Dr. Jill Halterman
- Organization
- University of Rochester
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 17, 2018
First Posted
June 4, 2018
Study Start
November 9, 2018
Primary Completion
May 6, 2024
Study Completion
June 28, 2025
Last Updated
September 17, 2025
Results First Posted
September 8, 2025
Record last verified: 2025-09